Daniele Corridoni
Overview
Explore the profile of Daniele Corridoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rana N, Privitera G, Kondolf H, Bulek K, Lechuga S, De Salvo C, et al.
Cell
. 2024 Feb;
187(4):1011-1015.
PMID: 38364781
No abstract available.
2.
Karmele E, Moldoveanu A, Kaymak I, Jugder B, Ursin R, Bednar K, et al.
Front Immunol
. 2024 Jan;
14:1291990.
PMID: 38179052
Inflammatory bowel disease (IBD) is an umbrella term for two conditions (Crohn's Disease and Ulcerative Colitis) that is characterized by chronic inflammation of the gastrointestinal tract. The use of pre-clinical...
3.
Corridoni D, Pizarro T
Inflamm Bowel Dis
. 2023 Jan;
29(2):334-336.
PMID: 36610699
No abstract available.
4.
Rana N, Privitera G, Kondolf H, Bulek K, Lechuga S, De Salvo C, et al.
Cell
. 2022 Jan;
185(2):283-298.e17.
PMID: 35021065
Gasdermins are a family of structurally related proteins originally described for their role in pyroptosis. Gasdermin B (GSDMB) is currently the least studied, and while its association with genetic susceptibility...
5.
Hardman C, Chen Y, Salimi M, Nahler J, Corridoni D, Jagielowicz M, et al.
Sci Immunol
. 2021 May;
6(59).
PMID: 34021026
Cutaneous group 2 innate lymphoid cells (ILC2) are spatially and epigenetically poised to respond to barrier compromise and associated immunological threats. ILC2, lacking rearranged antigen-specific receptors, are primarily activated by...
6.
De Salvo C, Buela K, Creyns B, Corridoni D, Rana N, Wargo H, et al.
J Clin Invest
. 2021 Jan;
131(5).
PMID: 33444291
Innate lymphoid cells (ILCs) are enriched at barrier surfaces, including the gastrointestinal tract. While most studies have focused on the balance between pathogenic group 1 ILCs (ILC1s) and protective ILC3s...
7.
Corridoni D, Antanaviciute A, Gupta T, Fawkner-Corbett D, Aulicino A, Jagielowicz M, et al.
Nat Med
. 2020 Aug;
26(9):1480-1490.
PMID: 32747828
Colonic antigen-experienced lymphocytes such as tissue-resident memory CD8 T cells can respond rapidly to repeated antigen exposure. However, their cellular phenotypes and the mechanisms by which they drive immune regulation...
8.
Bulek K, Zhao J, Liao Y, Rana N, Corridoni D, Antanaviciute A, et al.
J Clin Invest
. 2020 Jun;
130(8):4218-4234.
PMID: 32597834
Gasdermin D (GSDMD) induces pyroptosis via the pore-forming activity of its N-terminal domain, cleaved by activated caspases associated with the release of IL-1β. Here, we report a nonpyroptotic role of...
9.
Corridoni D, Chapman T, Antanaviciute A, Satsangi J, Simmons A
Inflamm Bowel Dis
. 2020 May;
26(11):1658-1668.
PMID: 32386055
The intestinal mucosa represents a unique environment where the coordinated function of diverse epithelial, mesenchymal, and immune cells maintains a physiologically balanced environment in the presence of gut microbiota. The...
10.
Menghini P, Corridoni D, Butto L, Osme A, Shivaswamy S, Lam M, et al.
Proc Natl Acad Sci U S A
. 2019 Dec;
116(52):26717-26726.
PMID: 31843928
Crohn's disease and ulcerative colitis are chronic and progressive inflammatory bowel diseases (IBDs) that are attributed to dysregulated interactions between the gut microbiome and the intestinal mucosa-associated immune system. There...